2021 Industry Review. NewLimit. New Funds. Longevity Biotech Job Fair.
Altos Labs. ODX. Impetus Grants. Healthspan Capital. Media is Code.
Unity, Rubedo, Oisin, Senolytic Therapeutics, + more. BioAge / Rubedo / Elevian fund raise.
On Deck Longevity Biotech. VitaDAO raise. Insilico Medicine, Continuum Biosciences, Vita Therapeutics. Mystery non-profit. Adventures in longevity.
Juvenescence IPO. AI Renaissance. Mystery Fund. Senolytics. Woof-extension.
Aducanumab! VitaDAO token sale. Lineage Cell. Non-Traditional.
Mitochondria x Longevity. BioAge Phase 2. Longevity SPACs.
Gerostate Alpha open investment. Foresight Institute Accelerator. Measuring Progress.
Biogen rollercoaster. CRISPR Therapeutics patient death.
Recursion Pharma IPO. China's Anti-aging Warren Buffet. The Longevity State.
Turn Bio funding. Unity Biotechnology and Denali Therapeutics updates. The Cost of Aging.
Michael Greve's €300M commitment. Dyno / Stealth / FOXO. Thoughts on what the aging field needs.